JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5751
Innovator US Small Cap Power Buffer ETF January
KJAN
$318M
| $33.4K | ﹤0.01% |
956
-1,648
| -63% | -$57.2K |
2023 Q4
2 quarters
|
|
5752
OppFi
OPFI
$507M
| $33.4K | ﹤0.01% |
9,843
-5,300
| -35% | -$16.1K |
2021 Q3
11 quarters
|
|
|
BLACR
5753
DELISTED
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
| $33.3K | ﹤0.01% |
300,000
| – | – |
2023 Q4
2 quarters
|
|
5754
Core Scientific Inc Tranche 2 Warrants
CORZZ
$1.34B
| – | – |
0
| – | – |
2024 Q1
1 quarter
|
|
5755
ClearPoint Neuro
CLPT
$349M
| $33.2K | ﹤0.01% |
6,158
-9,694
| -61% | -$56.1K |
2019 Q3
19 quarters
|
|
5756
El Paso Energy Capital Trust I
EP.PRC
$220M
| $33.1K | ﹤0.01% |
700
| – | – |
2024 Q1
1 quarter
|
|
5757
CALL
Darling Ingredients
DAR
$9.73B
| $33.1K | ﹤0.01% |
900
| – | – |
2023 Q4
2 quarters
|
|
5758
First Trust US Equity Opportunities ETF
FPX
$1.47B
| $32.9K | ﹤0.01% |
330
| – | – |
2022 Q4
6 quarters
|
|
|
BXMX
5759
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $32.8K | ﹤0.01% |
2,429
| – | – |
2023 Q2
4 quarters
|
|
5760
Imperial Petroleum
IMPP
$240M
| $32.7K | ﹤0.01% |
+8,427
| New | +$31.2K |
2024 Q2
0 quarters
|
|
5761
Kodiak Sciences
KOD
$6.19B
| $32.7K | ﹤0.01% |
13,913
+1,197
| +9% | +$4.05K |
2018 Q4
22 quarters
|
|
5762
Tactical Advantage ETF
FDAT
$36.7M
| $32.7K | ﹤0.01% |
+1,500
| New | +$32.6K |
2024 Q2
0 quarters
|
|
5763
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$3.96B
| $32.6K | ﹤0.01% |
+1,436
| New | +$32.4K |
2024 Q2
0 quarters
|
|
5764
Invesco Biotechnology & Genome ETF
PBE
$415M
| $32.4K | ﹤0.01% |
+500
| New | +$31.7K |
2024 Q2
0 quarters
|
|
5765
Verastem
VSTM
$715M
| $32.4K | ﹤0.01% |
10,862
-20,861
| -66% | -$172K |
2020 Q2
16 quarters
|
|
5766
Telecom Argentina
TEO
$5.02B
| $32.4K | ﹤0.01% |
+4,475
| New | +$35.7K |
2024 Q2
0 quarters
|
|
|
ATYR
5767
aTyr Pharma
ATYR
$28.8M
| $32.3K | ﹤0.01% |
20,686
-13,168
| -39% | -$22.9K |
2022 Q4
6 quarters
|
|
5768
New England Realty Associates
NEN
$180M
| $32.3K | ﹤0.01% |
450
| – | – |
2019 Q3
19 quarters
|
|
5769
Algoma Steel Group Warrant
ASTLW
$239K
| – | – |
0
| – | – |
2021 Q4
10 quarters
|
|
|
SWKH
5770
DELISTED
SWK Holdings
SWKH
| $32K | ﹤0.01% |
2,376
-6,000
| -72% | -$81.7K |
2022 Q2
8 quarters
|
|
|
AKTS
5771
DELISTED
Akoustis Technologies Inc
AKTS
| $31.9K | ﹤0.01% |
242,533
+203,544
| +522% | +$76.6K |
2019 Q2
20 quarters
|
|
5772
Werewolf Therapeutics
HOWL
$42.8M
| $31.9K | ﹤0.01% |
13,075
-58,109
| -82% | -$279K |
2021 Q2
12 quarters
|
|
|
LICY
5773
DELISTED
Li-Cycle Holdings Corp.
LICY
| $31.8K | ﹤0.01% |
4,874
-8,836
| -64% | -$48.8K |
2021 Q3
11 quarters
|
|
|
AFDM
5774
First Trust Exchange-Traded Fund III First Trust Active Factor International ETF
AFDM
$160M
| $31.7K | ﹤0.01% |
498
-28
| -5% | -$1.8K |
2023 Q3
3 quarters
|
|
|
LVRO
5775
DELISTED
Lavoro
LVRO
| $31.7K | ﹤0.01% |
6,000
| – | – |
2023 Q1
5 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.